Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the University of Edinburgh to commercialise its breakthrough Synthetic Super-Enhancer platform, Odysseus, to enable ...

Researchers developed a barcoded directed evolution system for engineered virus-like particles (eVLPs), creating a ...

The company's proprietary Synthetic Super-Enhancers (SSEs) are engineered DNA elements that act as docking stations for transcription factors uniquely expressed in aggressive cancer cells. This ...

The traditional approach has two major shortcomings– low integration efficiency and heterogeneity in gene expression due to ...